Structural and Functional Comparison of the RING Domains of Two p53 E3 Ligases, Mdm2 and Pirh2

The PyMOL Molecular Graphics System

DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147 · see citing works

NMRPipe: A multidimensional spectral processing system based on UNIX pipes

Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,994 · see citing works

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works

MOLMOL: A program for display and analysis of macromolecular structures

Koradi, R., Billeter, M., & Kurt Wüthrich, A. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00009-4 · Cited by 7,163 · see citing works

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

TANDEM: matching proteins with tandem mass spectra

Craig, R., & Beavis, R. C. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth092 · Cited by 2,553 · see citing works

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,387 · see citing works

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · see citing works

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works

The program XEASY for computer-supported NMR spectral analysis of biological macromolecules

Bartels, C., Xia, T.-H., Billeter, M., Güntert, P., & Kurt Wüthrich, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00417486 · Cited by 1,636 · see citing works

Themes and variations on ubiquitylation

Weissman, A. M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056563 · Cited by 1,472 · see citing works

Dali: a network tool for protein structure comparison

Holm, L., & Sander, C. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89105-7 · Cited by 1,462 · see citing works

Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · see citing works

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · see citing works

Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53

Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044 · see citing works

Structure of a c-Cbl–UbcH7 Complex

Zheng, N., Wang, P., Jeffrey, P. D., & Pavletich, N. P. (2000) · Cell · doi:10.1016/s0092-8674(00)00057-x · Cited by 839 · see citing works

Acetylation Is Indispensable for p53 Activation

Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838 · see citing works

A common open representation of mass spectrometry data and its application to proteomics research

Pedrioli, P. G. A., Eng, J. K., Hubley, R. M., Vogelzang, M., Deutsch, E. W., Raught, B., Pratt, B. S., Nilsson, E. J., Angeletti, R. H., Apweiler, R., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt1031 · Cited by 782 · see citing works

Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway

Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Pérès, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 726 · see citing works

Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation

Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 717 · see citing works

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B. T., Qing, W., Packman, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507493103 · Cited by 708 · see citing works

The ubiquitin ligase COP1 is a critical negative regulator of p53

Dornan, D., Wertz, I. E., Shimizu, H., Arnott, D. P., Frantz, G. D., Dowd, P., Rourke, K. O., Koeppen, H., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02514 · Cited by 700 · see citing works

ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor

Chen, D., Kon, N., Li, M., Zhang, W., Qin, J., & Gu, W. J. (2005) · Cell · doi:10.1016/j.cell.2005.03.037 · Cited by 539 · see citing works

Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517 · see citing works

Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression

Banks, L., Matlashewski, G., & Crawford, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09919.x · Cited by 505 · see citing works

Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.

Brzović, P. S., Rajagopal, P., Hoyt, D. W., King, M., & Klevit, R. E. (2001) · Nature Structural Biology · doi:10.1038/nsb1001-833 · Cited by 494 · see citing works

Transcription-independent pro-apoptotic functions of p53

Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468 · see citing works

Structure and E3‐ligase activity of the Ring–Ring complex of Polycomb proteins Bmi1 and Ring1b

Buchwald, G., van der Stoop, P. P. M., Weichenrieder, O., Anastassis Perrakis, A., van Lohuizen, M., & Sixma, T. K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601144 · Cited by 438 · see citing works

Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation

Rodríguez, M. S., Desterro, J. M. P., Laı́n, S., Lane, D. P., & Hay, R. T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8458-8467.2000 · Cited by 386 · see citing works

Three-dimensional structure of ectatomin from Ectatomma tuberculatum ant venom

Nolde, D. E., Sobol, A. G., Pluzhnikov, K. A., Grishin, E. V., & Arseniev, A. S. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00227465 · Cited by 363 · see citing works

Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4

Marine, J.-C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., & Lozano, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401912 · Cited by 352 · see citing works

E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages

Christensen, D. E., Brzovic, P. S., & Klevit, R. E. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1295 · Cited by 351 · see citing works

The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto‐oncoprotein PML.

Borden, K. L. B., Boddy, M. N., Lally, J., O’Reilly, N., Martin, S. R., Howe, K. M., Solomon, E., & Freemont, P. S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07139.x · Cited by 328 · see citing works

Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans

Linke, K., Mace, P. D., Smith, C. A., Vaux, D. L., Silke, J., & Day, C. L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402309 · Cited by 288 · see citing works

Cytoplasmic destruction of p53 by the endoplasmic reticulum‐resident ubiquitin ligase ‘Synoviolin’

Yamasaki, S., Yagishita, N., Sasaki, T., Nakazawa, M., Kato, Y., Yamadera, T., Bae, E.-K., Toriyama, S., Ikeda, R., Zhang, L., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601490 · Cited by 275 · see citing works

Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53

Gu, J., Kawai, H., Nie, L., Kitao, H., Wiederschain, D., Jochemsen, A. G., Parant, J. M., Lozano, G., & Yuan, Z.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200150200 · Cited by 265 · see citing works

Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells <i>in vivo</i>

Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M., Doumont, G., Bellefroid, E., & Marine, J.-C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508476103 · Cited by 260 · see citing works

Structure of a Bmi-1-Ring1B Polycomb Group Ubiquitin Ligase Complex

Li, Z., Cao, R., Wang, M., Myers, M. P., Zhang, Y., & Xu, R.-M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602461200 · Cited by 246 · see citing works

E4F1 Is an Atypical Ubiquitin Ligase that Modulates p53 Effector Functions Independently of Degradation

Cam, L. L., Linares, L. K., Paul, C., Julien, E., Lacroix, M., Hatchi, E., Triboulet, R., Bossis, G., Shmueli, A., Rodríguez, M. S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.031 · Cited by 241 · see citing works

C-Terminal Ubiquitination of p53 Contributes to Nuclear Export

Lohrum, M. A. E., Woods, D. B., Ludwig, R. L., Bálint, É., & Vousden, K. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8521-8532.2001 · Cited by 237 · see citing works

Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., & Jochemsen, A. G. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve227 · Cited by 234 · see citing works

MDMX: from bench to bedside

Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works

MdmX Protects p53 from Mdm2-Mediated Degradation

Jackson, M. W., & Berberich, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1001-1007.2000 · Cited by 211 · see citing works

The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity

Poyurovsky, M. V., Priest, C., Kentsis, A., Borden, K. L., Pan, Z., Pavletich, N., & Prives, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601465 · Cited by 203 · see citing works

Structures of the cIAP2 RING Domain Reveal Conformational Changes Associated with Ubiquitin-conjugating Enzyme (E2) Recruitment

Mace, P. D., Linke, K., Feltham, R., Schumacher, F., Smith, C. A., Vaux, D. L., Silke, J., & Day, C. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804753200 · Cited by 171 · see citing works

An essential function of the extreme C-terminus of MDM2 can be provided by MDMX

Uldrijan, S., Pannekoek, W., & Vousden, K. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601469 · Cited by 170 · see citing works

BRCA1 RING Domain Cancer-predisposing Mutations

Brzović, P. S., Meza, J. E., King, M., & Klevit, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106551200 · Cited by 133 · see citing works

Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53

Kostic, M., Matt, T., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.027 · Cited by 128 · see citing works

Structural Model of the UbcH5B/CNOT4 Complex Revealed by Combining NMR, Mutagenesis, and Docking Approaches

Dominguez, C., Bonvin, A. M. J. J., Winkler, G. S., van Schaik, F. M. A., Timmers, H. T. M., & Boelens, R. (2004) · Structure · doi:10.1016/j.str.2004.03.004 · Cited by 124 · see citing works

Global Map of SUMO Function Revealed by Protein-Protein Interaction and Genetic Networks

Makhnevych, T., Sydorskyy, Y., Xin, X., Srikumar, T., Vizeacoumar, F. J., Jeram, S. M., Li, Z., Bahr, S., Andrews, B., Boone, C. M., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.025 · Cited by 121 · see citing works

Molecular basis of Pirh2-mediated p53 ubiquitylation

Sheng, Y., Laister, R. C., Lemak, A. S., Wu, B., Tai, E., Duan, S., Lukin, J. A., Sunnerhagen, M., Srisailam, S., Karra, M., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1521 · Cited by 116 · see citing works

Regulation of p53 Localization and Activity by Ubc13

Laine, A. M., Topisirović, I., Zhai, D., Reed, J. C., Borden, K. L. B., & Ronai, Z. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01156-06 · Cited by 101 · see citing works

Expression of Pirh2, a Newly Identified Ubiquitin Protein Ligase, in Lung Cancer

Duan, W., Gao, L., Druhan, L. J., Zhu, W., Morrison, C., Otterson, G. A., & Villalona-Calero, M. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh292 · Cited by 96 · see citing works

Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer

Logan, I. R., Gaughan, L., McCracken, S. R., Sapountzi, V., Leung, H. Y., & Robson, C. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00147-06 · Cited by 88 · see citing works

The RING domain of Mdm2 can inhibit cell proliferation.

Dang, J., Kuo, M.-L., Eischen, C. M., Stepanova, L., Sherr, C. J., & Roussel, M. F. (2002) · PubMed · Cited by 86 · see citing works

p53's Believe It or Not: Lessons on Transcription-Independent Death

Chipuk, J. E., & Green, D. R. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1025365432325 · Cited by 81 · see citing works

Mdmx and Mdm2: Brothers in Arms?

Marine, J., & Jochemsen, A. G. (2004) · Cell Cycle · doi:10.4161/cc.3.7.998 · Cited by 77 · see citing works

A Second p53 Binding Site in the Central Domain of Mdm2 Is Essential for p53 Ubiquitination

Ma, J., Martin, J. D., Zhang, H., Auger, K. R., Ho, T. F., Kirkpatrick, R. B., Grooms, M. H., Johanson, K., Tummino, P. J., Copeland, A. R. A., et al. (2006) · Biochemistry · doi:10.1021/bi060661u · Cited by 68 · see citing works

Control of p53 multimerization by Ubc13 is JNK-regulated

Topisirović, I., Gutierrez, G. J., Chen, M., Appella, E., Borden, K. L. B., & Ronai, Z. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900596106 · Cited by 56 · see citing works

Supramolecular Complex Formation between Rad6 and Proteins of the p53 Pathway during DNA Damage-Induced Response

Lyakhovich, A., & Shekhar, M. P. V. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2463-2475.2003 · Cited by 49 · see citing works

Differential response between the p53 ubiquitin–protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells

Duan, W., Gao, L., Wu, X., Zhang, Y., Otterson, G. A., & Villalona-Calero, M. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.07.005 · Cited by 38 · see citing works

Solution Structure of the Ubiquitin-conjugating Enzyme UbcH5B

Houben, K., Dominguez, C., van Schaik, F. M. A., Timmers, H. T. M., Bonvin, A. M. J. J., & Boelens, R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.054 · Cited by 33 · see citing works

MDM2, MDMX and p53 in oncogenesis and cancer therapy

Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works

Regulating tumor suppressor genes: post-translational modifications

Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449 · see citing works

Crosstalk Between Mammalian Autophagy and the Ubiquitin-Proteasome System

Kocatürk, N. M., & Gözüaçık, D. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00128 · Cited by 415 · see citing works

p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PL pro via E3 ubiquitin ligase RCHY1

Ma‐Lauer, Y., Carbajo-Lozoya, J., Hein, M. Y., Müller, M. A., Deng, W., Lei, J., Meyer, B., Kusov, Y., von Brunn, B., Bairad, D. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603435113 · Cited by 214 · see citing works

RINGs hold the key to ubiquitin transfer

Budhidarmo, R., Nakatani, Y., & Day, C. L. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.11.001 · Cited by 206 · see citing works

The role of ubiquitin modification in the regulation of p53

Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168 · see citing works

Anti-Ro52 Autoantibodies from Patients with Sjögren's Syndrome Inhibit the Ro52 E3 Ligase Activity by Blocking the E3/E2 Interface

Espinosa, A., Hennig, J., Ambrosi, A., Anandapadmanaban, M., Abelius, M. S., Sheng, Y., Nyberg, F., Arrowsmith, C. H., Sunnerhagen, M., & Wahren‐Herlenius, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.241786 · Cited by 90 · see citing works

The MDM2 gene family

Mendoza, M. J., Mandani, G., & Momand, J. A. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2013-0027 · Cited by 86 · see citing works

Contribution of E3-Ubiquitin Ligase Activity to HIV-1 Restriction by TRIM5α rh : Structure of the RING Domain of TRIM5α

Lienlaf, M., Hayashi, F., Nunzio, F. D., Tochio, N., Kigawa, T., Yokoyama, S., & Diaz‐Griffero, F. (2011) · Journal of Virology · doi:10.1128/jvi.00497-11 · Cited by 86 · see citing works

E2 Conjugating Enzyme Selectivity and Requirements for Function of the E3 Ubiquitin Ligase CHIP

Soss, S. E., Yue, Y., Dhe‐Paganon, S., & Chazin, W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224006 · Cited by 84 · see citing works

Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies

Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 66 · see citing works

MDMX contains an autoinhibitory sequence element

Biśta, M., Petrovich, M., & Fersht, A. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317398110 · Cited by 57 · see citing works

Arsenic Trioxide Reactivates Proteasome-Dependent Degradation of Mutant p53 Protein in Cancer Cells in Part via Enhanced Expression of Pirh2 E3 Ligase

Yan, W., Jung, Y.-S., Zhang, Y., & Chen, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103497 · Cited by 51 · see citing works

Zinc deficiency causes neural tube defects through attenuation of p53 ubiquitylation

Li, H., Zhang, J., & Niswander, L. A. (2018) · Development · doi:10.1242/dev.169797 · Cited by 52 · see citing works

MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4

Marcar, L., Ihrig, B., Hourihan, J. M., Bray, S. E., Quinlan, P., Jordan, L. B., Thompson, A. M., Hupp, T. R., & Meek, D. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127713 · Cited by 42 · see citing works

P53 in the impaired lungs

Uddin, M. A., & Barabutis, N. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102952 · Cited by 35 · see citing works

Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers

Doleželová, P., Cetkovská, K., Vousden, K. H., & Uldrijan, S. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19445 · Cited by 33 · see citing works

Regulation of transcriptional activators by DNA-binding domain ubiquitination

Landré, V., Revi, B., Gil-Mir, M., Verma, C. S., Hupp, T. R., Gilbert, N., & Ball, K. L. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.42 · Cited by 32 · see citing works

It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53

Love, I. M., & Grossman, S. R. (2012) · Genes & Cancer · doi:10.1177/1947601912455198 · Cited by 28 · see citing works

Regulation of p53 by E3s

Pan, M., & Blattner, C. (2021) · Cancers · doi:10.3390/cancers13040745 · Cited by 27 · see citing works

Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradationPreprint

Yan, W., Scoumanne, A., Jung, Y.-S., Xu, E., Zhang, J., Zhang, Y., Ren, C., Sun, P., & Chen, X. (2016) · Genes & Development · doi:10.1101/gad.271890.115 · Cited by 21 · see citing works

Nutrient copper signaling promotes protein turnover by allosteric activation of ubiquitin E2D conjugasesPreprint

Opazo, C. M., Lotan, A., Xiao, Z., Zhang, B., Greenough, M. A., Lim, C. M., Trytell, H., Ramírez, A., Ukuwela, A. A., Mawal, C. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.15.431211 · Cited by 21 · see citing works

Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain

Ilic, V. K., Egorova, O., Tsang, E., Gatto, M., Wen, Y., Zhao, Y., & Sheng, Y. (2022) · Biomolecules · doi:10.3390/biom12050643 · Cited by 20 · see citing works

MDM2 Mediates Nonproteolytic Polyubiquitylation of the DEAD-Box RNA Helicase DDX24

Yamauchi, T., Nishiyama, M., Moroishi, T., Yumimoto, K., & Nakayama, K. I. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00320-14 · Cited by 20 · see citing works

Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops

Ponnuswamy, A., Hupp, T. R., & Fåhræus, R. (2012) · Genes & Cancer · doi:10.1177/1947601912454140 · Cited by 18 · see citing works

Recognition of an Ala-rich C-degron by the E3 ligase Pirh2

Wang, X., Li, Y., Yan, X., Yang, Q., Zhang, B., Zhang, Y., Yuan, X., Jiang, C., Chen, D., Liu, Q., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38173-6 · Cited by 14 · see citing works

A site-directed mutagenesis study of the MdmX RING domain

Egorova, O., & Sheng, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.065 · Cited by 10 · see citing works

Proteasomal control of transcription factors: mechanisms, regulation and dysregulation

Larsen, F. B., Kragelund, B. B., Lindorff‐Larsen, K., Heidarsson, P. O., & Hartmann‐Petersen, R. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06103-6 · Cited by 6 · see citing works

Mice Deficient in the RNA-Binding Protein Zfp871 Are Prone to Early Death and Steatohepatitis in Part through the p53–Mdm2 Axis

Mohibi, S., Zhang, J., Chen, M., & Chen, X. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0239 · Cited by 6 · see citing works

Rational design of promiscuous binding modulators of p53 inducing E3(Ub)-ligases (Mdm2 and Pirh2) as anticancer agents: an in silico approach

Niazi, S., & Purohit, M. N. (2015) · MedChemComm · doi:10.1039/c5md00319a · Cited by 5 · see citing works

p53 regulation by ubiquitin and ubiquitin-like modifications

Wang, Y., Zhang, C., Wang, J., & Liu, J. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00067-0 · Cited by 5 · see citing works

p53, Pirh2, and L1CAM as Promising Prognostic Biomarkers of Endometrial Carcinoma: An Immunohistochemical and Genetic Study

Abdelrahman, A. E., Salem, A., Attar, A. Z. A., Elsebai, E. A., Samy, W. M., Ibrahim, M. A., & Ibrahim, H. (2022) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000001073 · Cited by 4 · see citing works

Zooming into the structure-function of RING finger proteins for anti-cancer therapeutic applications.

George, M., Masamba, P., Iwalokun, B. A., & Kappo, A. P. (2023) · PubMed Central · Cited by 3 · see citing works

The Role of Pirh2 E3 Ligases in Ubiquitination and p73 Regulation

Abou Zeinab, R. M. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3610vx4f · Cited by 1 · see citing works

Dissecting the Interaction between p53 and TRIM24

Duncan, A. D. (2011) · Digital Commons-TMC (Texas Medical Center)

DigitalCommons@Th e Texas Medical Center

Gsbs, U., & Hong, J. Y. (2011)

Structural and Functional Characterization of the Human Mdm2 and MdmX RING Domains

Egorova, O. (2014) · YorkSpace (York University)

An Integrated Structure-based Approach for the Development of MDM2 inhibitors

Sheng, Y. (2021) · International Electronic Conference on Cancers (IECC) · doi:10.3390/iecc2021-09208

The tumour suppressor p53 as a supporter of DNA replication

Klusmann, I. (2018) · doi:10.53846/goediss-7143

Formation et régulation du complexe polymérase du virus de la rougeole

Bloyet, L.-M. (2015) · doi:10.70675/39007b42zbb49z41b5zb5ffz4d00c60c4b16

RING finger E3 ubiquitin ligases: novel therapeutic opportunities in melanoma

Zhang, J.-F., Li, L.-T., Yang, Y.-Y., Zhang, S.-C., Gao, C., Zhu, X., Xin, H., & Li, X. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00940-w

Identification and Characterization of Two Novel Isoforms of Pirh2 Ubiquitin Ligase That Negatively Regulate p53 Independent of RING Finger Domains

Corcoran, C. A., Montalbano, J., Hong, S., He, Q., Huang, Y. K., & Sheikh, M. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024232 · Cited by 21 · see citing works

A site-directed mutagenesis study of the MdmX RING domain

Egorova, O., & Sheng, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.065 · Cited by 10 · see citing works

Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells

Egorova, O., Lau, H. H., McGraphery, K., & Sheng, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041309 · Cited by 17 · see citing works

RING Domain–Mediated Interaction Is a Requirement for MDM2's E3 Ligase Activity

Kawai, H., Lopez-Pajares, V., Kim, M. M., Wiederschain, D., & Yuan, Z.-M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1313 · Cited by 156 · see citing works

Molecular basis of Pirh2-mediated p53 ubiquitylation

Sheng, Y., Laister, R. C., Lemak, A. S., Wu, B., Tai, E., Duan, S., Lukin, J. A., Sunnerhagen, M., Srisailam, S., Karra, M., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1521 · Cited by 116 · see citing works